TNDM EBITDA | Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (TNDM) EBITDA

2026-06-30: Basis Reported; EBITDA -$9.32M*; Operating income -$13.79M; Depreciation and amortization $4.47M*.
2026-03-31: Basis Reported; EBITDA -$12.93M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $12.79M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$18.37M*; Operating income -$22.86M; Depreciation and amortization $4.49M*.

Complete source-backed ebitda history.

Available history: 2012-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$9.32M*	-$13.79M	$4.47M*	$254.56M	-3.66%*	$4.05M*	-$34.63M*	$109.78M	(m)	$111.64M	$510.00K
2026-03-31	Reported	-$12.93M	(m)	(m)	(m)	-5.23%	$6.27M	$11.05M	$110.43M	(m)	$108.19M	$516.00K
2025-12-31	Reported	$12.79M	(m)	(m)	(m)	4.40%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$18.37M*	-$22.86M	$4.49M*	$249.25M	-7.37%*	$4.09M*	$8.26M*	$114.96M	(m)	$108.44M	-$3.98M
2025-06-30	Reported	-$47.44M*	-$51.81M	$4.37M*	$240.68M	-19.71%*	$6.21M*	-$9.50M*	$114.82M	(m)	$109.60M	-$5.32M
2025-03-31	Reported	-$116.57M	(m)	(m)	(m)	-49.73%	$2.96M	-$18.28M	$116.02M	(m)	$113.85M	$8.47M
2024-12-31	Reported	$3.66M	(m)	(m)	(m)	1.30%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$21.88M*	-$26.09M	$4.21M*	$243.97M	-8.97%*	$5.24M*	$26.78M*	$119.32M	(m)	$99.64M	$637.00K
2024-06-30	Reported	-$26.67M*	-$30.77M	$4.11M*	$221.91M	-12.02%*	$6.47M*	-$5.28M*	$109.12M	(m)	$94.24M	$1.07M
2024-03-31	Reported	-$37.64M	(m)	(m)	(m)	-19.63%	$4.46M	-$8.00M	$97.00M	(m)	$90.11M	$3.19M
2023-12-31	Reported	-$31.03M	(m)	(m)	(m)	-15.77%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$27.52M*	-$31.55M	$4.02M*	$185.62M	-14.83%*	$5.40M*	$55.00K*	$95.87M	(m)	$79.33M	$2.23M
2023-06-30	Reported	-$34.54M*	-$38.81M	$4.26M*	$195.92M	-17.63%*	$7.38M*	-$6.32M*	$94.18M	(m)	$97.61M	$1.15M
2023-03-31	Reported	-$124.42M	(m)	(m)	(m)	-73.46%	$8.83M	-$18.33M	$86.48M	(m)	$89.81M	$287.00K
2022-12-31	Reported	-$14.14M	(m)	(m)	(m)	-6.41%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$43.98M*	-$47.49M	$3.51M*	$204.55M	-21.50%*	$13.71M*	$23.94M*	$100.12M	(m)	$84.10M	$1.62M
2022-06-30	Reported	-$8.69M*	-$12.24M	$3.55M*	$200.26M	-4.34%*	$12.12M*	$6.90M*	$98.32M	$33.57M	$80.61M	$2.11M
2022-03-31	Reported	-$11.71M	(m)	(m)	(m)	-6.66%	$2.64M	$13.80M	$84.81M	$33.16M	$73.27M	-$1.72M
2021-12-31	Reported	$16.26M	(m)	(m)	(m)	7.74%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$11.12M*	$7.72M	$3.40M*	$179.63M	6.19%*	$3.10M*	$34.14M*	$82.88M	$24.10M	$64.92M	$54.00K
2021-06-30	Reported	$8.87M*	$5.43M	$3.44M*	$172.14M	5.15%*	$1.81M*	$28.89M*	$79.69M	$20.50M	$66.52M	$61.00K
2021-03-31	Reported	$248,000.00	(m)	(m)	(m)	0.18%	$3.52M	$28.68M	$67.75M	$17.96M	$58.56M	-$117.00K
2020-12-31	Reported	$22.09M	(m)	(m)	(m)	13.14%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$1.98M*	-$1.01M	$2.99M*	$123.60M	1.60%*	$6.76M*	$14.56M*	$58.29M	$16.09M	$50.23M	$39.00K
2020-06-30	Reported	-$9.83M*	-$12.04M	$2.21M*	$109.24M	-9.00%*	$9.79M*	$15.50M*	$54.85M	$15.99M	$50.44M	-$2.08M
2020-03-31	Reported	-$11.74M	(m)	(m)	(m)	-11.99%	$6.77M	-$20.63M	$47.66M	$14.12M	$49.72M	$98.00K
2019-12-31	Reported	$3.79M	(m)	(m)	(m)	3.49%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$4.52M*	-$6.00M	$1.48M*	$94.66M	-4.78%*	$4.62M*	$23.02M*	$43.97M	$12.04M	$44.65M	$72.00K
2019-06-30	Reported	-$357.00K*	-$1.86M	$1.51M*	$93.25M	-0.38%*	$6.76M*	$3.57M*	$43.35M	$11.20M	$40.56M	$0.00
2019-03-31	Reported	-$9.56M	(m)	(m)	(m)	-14.48%	$1.41M	-$4.12M	$32.64M	$9.39M	$34.96M	$0.00
2018-12-31	Reported	$2.03M	(m)	(m)	(m)	2.66%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$14.25M*	-$15.71M	$1.46M*	$46.26M	-30.81%*	$1.01M*	-$3.46M*	$24.47M	$8.00M	$29.51M	$0.00
2018-06-30	Reported	-$12.59M*	-$14.00M	$1.41M*	$34.13M	-36.90%*	$573.00K*	-$6.72M*	$19.04M	$6.46M	$22.63M	(m)
2018-03-31	Reported	-$13.99M	(m)	(m)	(m)	-51.30%	$514.00K	-$12.27M	$15.87M	$5.97M	$20.91M	(m)
2017-12-31	Reported	-$7.45M	(m)	(m)	(m)	-18.50%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$11.45M*	-$13.17M	$1.72M*	$27.00M	-42.38%*	$244.00K*	-$19.02M*	$15.13M	$4.91M	$20.13M	(m)
2017-06-30	Reported	-$17.38M*	-$18.97M	$1.59M*	$21.33M	-81.50%*	$1.41M*	(m)	$13.32M	$4.87M	$22.10M	(m)
2017-03-31	Reported	-$19.8M	(m)	(m)	(m)	-104.33%	$2.64M	(m)	$12.22M	$5.13M	$22.85M	(m)
2016-12-31	Reported	-$11.87M	(m)	(m)	(m)	-41.07%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$27.11M*	-$28.41M	$1.30M*	(m)	(m)	$2.14M*	(m)	$13.87M	$6.15M	$20.68M	(m)
2016-06-30	Reported	-$15.67M*	-$17.05M	$1.38M*	(m)	(m)	$2.10M*	(m)	$14.81M	$4.14M	$21.09M	(m)
2016-03-31	Reported	-$17.9M	(m)	(m)	(m)	-89.26%	$1.95M	(m)	$13.13M	$4.17M	$22.00M	(m)
2015-12-31	Reported	-$10M	(m)	(m)	(m)	-34.34%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$17.51M*	-$18.70M	$1.20M*	(m)	(m)	$1.74M*	(m)	$10.20M	$5.09M	$19.12M	(m)
2015-06-30	Reported	-$17.44M*	-$18.67M	$1.23M*	(m)	(m)	$1.75M*	(m)	$10.90M	$3.87M	$19.60M	(m)
2015-03-31	Reported	-$19.23M	(m)	(m)	(m)	-156.22%	$600.00K	(m)	$9.50M	$3.86M	$19.36M	(m)
2014-12-31	Reported	-$16.2M	(m)	(m)	(m)	-90.56%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$17.84M*	-$19.01M	$1.17M*	(m)	(m)	$970.00K*	(m)	$9.12M	$4.51M	$18.89M	(m)
2014-06-30	Reported	-$17.32M*	-$18.32M	$997.00K*	(m)	(m)	$1.07M*	(m)	$6.81M	$3.70M	$18.07M	(m)
2014-06-30	Reported	(m)	-$18.32M	(m)	(m)	(m)	(m)	(m)	$6.81M	$3.70M	$18.07M	(m)
2014-03-31	Reported	-$19.92M	(m)	(m)	(m)	-246.96%	$1.62M	-$16.96M	$7.20M	$3.66M	$18.04M	(m)
2013-12-31	Reported	-$15.76M	(m)	(m)	(m)	-153.83%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$11.37M*	-$12.13M	$756.64K*	(m)	(m)	$1.11M*	(m)	$5.24M	$2.65M	$12.01M	(m)
2013-06-30	Reported	-$12.75M*	-$13.68M	$922.38K*	(m)	(m)	$514.97K*	(m)	$5.12M	$2.76M	$11.32M	(m)
2013-03-31	Reported	-$6.38M	(m)	(m)	(m)	-116.92%	$901.11K	-$8.81M	$3.42M	$2.32M	$6.88M	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Rolling	(m)	-$45.80M*	(m)	$1.04B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2026-03-31	Rolling	(m)	-$83.81M*	(m)	$1.03B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-12-31	Reported	-$169.59M	(m)	(m)	(m)	-16.71%	$19.95M	-$9.72M	$468.72M	(m)	$444.99M	$4.44M
2025-12-31	Rolling	(m)	-$187.26M*	(m)	$1.01B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Rolling	(m)	-$196.13M*	(m)	$1.01B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-06-30	Rolling	(m)	-$199.36M*	(m)	$1.00B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-03-31	Rolling	(m)	-$178.33M*	(m)	$982.95M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-12-31	Reported	-$82.52M	(m)	(m)	(m)	-8.78%	$19.23M	$24.23M	$450.63M	(m)	$389.82M	$4.16M
2024-12-31	Rolling	(m)	-$99.13M*	(m)	$940.20M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Rolling	(m)	-$133.60M*	(m)	$854.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-06-30	Rolling	(m)	-$139.06M*	(m)	$796.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-03-31	Rolling	(m)	-$147.09M*	(m)	$770.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-12-31	Reported	-$217.52M	(m)	(m)	(m)	-29.09%	$26.80M	-$31.81M	$380.03M	(m)	$352.50M	$2.36M
2023-12-31	Rolling	(m)	-$233.23M*	(m)	$747.72M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Rolling	(m)	-$215.95M*	(m)	$771.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-06-30	Rolling	(m)	-$231.90M*	(m)	$790.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-03-31	Rolling	(m)	-$205.33M*	(m)	$794.69M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-12-31	Reported	-$78.52M	(m)	(m)	(m)	-9.80%	$34.10M	$50.46M	$388.23M	(m)	$335.68M	$1.74M
2022-12-31	Rolling	(m)	-$92.85M*	(m)	$801.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Rolling	(m)	-$62.33M*	(m)	$790.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-06-30	Rolling	(m)	-$7.12M*	(m)	$765.79M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-03-31	Rolling	(m)	$10.55M*	(m)	$737.67M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-12-31	Reported	$36.5M	(m)	(m)	(m)	5.19%	$14.18M	$111.36M	$326.58M	$92.05M	$261.51M	$335.00K
2021-12-31	Rolling	(m)	$22.65M*	(m)	$702.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Rolling	(m)	$28.58M*	(m)	$660.87M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	$19.85M*	(m)	$604.84M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	$2.38M*	(m)	$541.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	$2.49M	(m)	(m)	(m)	0.50%	$27.41M	$24.67M	$238.31M	$63.57M	$204.90M	-$1.90M
2020-12-31	Rolling	(m)	-$7.96M*	(m)	$498.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$24.48M*	(m)	$439.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$29.47M*	(m)	$410.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$19.30M*	(m)	$394.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$10.65M	(m)	(m)	(m)	-2.94%	$19.54M	$41.91M	$168.09M	$45.20M	$165.74M	$149.00K
2019-12-31	Rolling	(m)	-$16.72M*	(m)	$362.31M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$18.31M*	(m)	$330.11M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$28.01M*	(m)	$281.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$40.14M*	(m)	$222.58M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$38.81M	(m)	(m)	(m)	-21.11%	$2.99M	-$8.32M	$94.04M	$29.23M	$105.23M	$51.00K
2018-12-31	Rolling	(m)	-$44.63M*	(m)	$183.87M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$54.77M*	(m)	$147.96M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$52.23M*	(m)	$128.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$57.20M*	(m)	$115.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$56.08M	(m)	(m)	(m)	-52.12%	$5.72M	-$66.14M	$63.51M	$20.66M	$86.38M	$8.00K
2017-12-31	Rolling	(m)	-$62.94M*	(m)	$107.60M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$66.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$81.95M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$80.04M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$72.56M	(m)	(m)	(m)	-86.13%	$8.93M	-$61.17M	$60.66M	$18.81M	$82.83M	-$15.00K
2016-12-31	Rolling	(m)	-$78.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$75.93M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$66.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$67.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$64.18M	(m)	(m)	(m)	-88.09%	$5.76M	(m)	$46.27M	$16.96M	$78.62M	$10.00K
2015-12-31	Rolling	(m)	-$69.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$75.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$75.59M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$71.28M	(m)	(m)	(m)	-143.35%	$4.41M	(m)	$34.47M	$15.79M	$75.12M	$71.00K
2014-03-31	Rolling	(m)	-$63.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$46.27M	(m)	(m)	(m)	-159.50%	$4.01M	(m)	$22.84M	$11.08M	$44.52M	(m)
2013-12-31	Rolling	(m)	-$49.43M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$31.02M	(m)	(m)	(m)	-1253.17%	$4.53M	(m)	$3.82M	$9.01M	$22.69M	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
IRADIMED CORP (IRMD)	United States	$1.089B	52.92
PROCEPT BioRobotics Corp (PRCT)	United States	$1.001B	-11.77
ARTIVION, INC. (AORT)	United States	$1.123B	-345.09
Beta Bionics, Inc. (BBNX)	United States	$0.979B	-9.66
SpyGlass Pharma, Inc. (SGP)	United States	$0.925B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)	United States	$1.234B	-193.02
SI-BONE, Inc. (SIBN)	United States	$0.830B	-49.82
MIMEDX GROUP, INC. (MDXG)	United States	$0.687B	89.92
ANGIODYNAMICS INC (ANGO)	United States	$0.632B	-13.02
ORTHOPEDIATRICS CORP (KIDS)	United States	$0.592B